• 沒有找到結果。

為使研究更具應用性,減低研究偏差,日後在進行相關的研究時,建議加入 以下幾點考量,使研究更趨完善:

一、透過相關體育單位之協助,提高優秀運動選手之研究參與率,進行更為廣泛 之調查,提升整體受試者之人數。

二、探討基因與運動之間的關連性,可考慮將運動選手依運動項目分別進行探 討,以得到更精確且更具應用性之研究結果。

三、建議集中探討曾於國際級或世界級比賽中獲獎之頂尖選手,了解其基因型分 布之間是否具有相同之趨勢,可能得到更具有意義之結果。

四、受限於研究之人力及經費,受試者召募乃採立意取樣,而非隨機取樣,乃至 受試者主要來自臺北縣、市與桃園地區之大學運動選手,倘若在人力、經費 足以支援之下,應執行遍佈全國之大型調查,以求研究結果更具代表性。如 此則可依此結果作為國家運動選才之依據,而根據選手相關之運動基因,適 才適時給予妥切的營養諮詢與運動訓練,則可及早培養及成就優秀之運動國 手。

表 4.1 ACE、ACTN3 及 AGT 基因型和所對應之運動能力1

Table 4.1 ACE, ACTN3, and AGT genotypes and the corresponding exercise capacity. 1

1The association of genotype with the corresponding exercise ability was cited from studies (Busjahn et al., 1997; Clarkson et al., 2005; Myerson et al., 1999).

Endurance genotype

Middle genotype

Sprint genotype

ACE II ID DD

ACTN3 XX RX RR

AGT MM MT TT

表 4.2 受試者之生理參數1

Table 4.2 Anthropometric parameters of the participants.1

1 p <.05, data (mean ± S.D.) with different letters were significantly different, as analyzed by one-way ANOVA.

Male athletes (n = 146) Female athletes (n = 178)

Endurance (n = 57)

Sprint (n = 89)

Control

(n = 100) p Endurance

(n = 57)

Sprint

(n = 121) Control

(n = 100) p

Age (years) 20.3 ± 1.5b 20.0 ± 1.4b 21.4 ± 2.2a .0003 20.3 ± 1.2b 20.0 ± 1.2c 21.4 ± 2.0a <.0001

Height (cm) 175.7 ± 5.8a 178.1 ± 5.9a 172.9 ± 8.5b <.0001 163.6 ± 4.1a 165.5 ± 5.2a 160.7 ± 4.8b <.0001

Weight (kg) 74.4 ± 14.2a 73.3 ± 11.8a 68.4 ± 8.5b .0303 56.8 ± 6.5ab 58.9 ± 8.1a 55.0 ± 9.7b .0099

4.3 男性受試者之 ACE、ACTN3 及 AGT 基因型1

Table 4.3 ACE, ACTN3, and AGT genotypes of the male participants.1

1P value was analyzed by χ2 test, and the comparison was made with the corresponding control group.

#P <0.001, the comparison was made with the corresponding sprint group.

Group Genotype distribution Allele frequency

n

ACE

I/I, n (%) I/D, n (%) D/D, n (%) p I % D % p

Endurance 57 22 (38.6) 30 (52.6) 5 (8.8) .0446# 64.9 35.1 .8701

Sprint 89 47 (52.8) 39 (43.8) 3 (3.4) .0102 74.7 25.3 .1780

Control 100 48 (48.0) 36 (36.0) 16 (16.0) - 66.0 34.0 -

n

ACTN3

X/X, n (%) X/R, n (%) R/R, n (%) p X % R % p

Endurance 57 13 (22.8) 27 (47.4) 17 (29.8) .2441 46.5 53.5 .5218

Sprint 89 13 (14.6) 40 (44.9) 36 (40.5) .2469 37.0 63.0 .4695

Control 100 14 (14.0) 56 (56.0) 30 (30.0) - 42.0 58.0 -

n

AGT

M/M, n (%) M/T, n (%) T/T, n (%) p M % T % p

Endurance 57 3 (5.3) 16 (28.1) 38 (66.7) .2081 19.4 80.6 .6601

Sprint 89 4 (4.5) 16 (18.0) 69 (77.5) .5884 13.5 86.5 .4912

Control 100 8 (8.0) 18 (18.0) 74 (74.0) - 17.0 83.0 -

表 4.4 女性受試者之 ACE、ACTN3 及 AGT 基因型1

Table 4.4 ACE, ACTN3, and AGT genotypes of the female participants.1

1P value was analyzed by χ2 test, and the comparison was made with the corresponding control group.

#P <0.05, the comparison was made with the corresponding sprint group.

Group Genotype distribution Allele frequency

n

ACE

I/I, n (%) I/D, n (%) D/D, n (%) p I % D % p

Endurance 57 28 (49.1) 25 (43.9) 4 (7.0) .0475# 71.1 28.9 .4826# Sprint 121 41 (33.9) 63 (52.1) 17 (14.0) .3133 59.9 40.1 .3332

Control 100 40 (40.0) 50 (50.0) 10 (10.0) - 66.5 33.5 -

n

ACTN3

X/X, n (%) X/R, n (%) R/R, n (%) p X % R % p

Endurance 57 25 (43.9) 21 (36.8) 11 (19.3) .0025# 62.3 37.7 .0298# Sprint 121 16 (13.2) 65 (53.7) 40 (33.1) <.0001 40.0 60.0 .3181

Control 100 21 (21.0) 52 (52.0) 27 (27.0) - 47.0 53.0 -

n

AGT

M/M, n (%) M/T, n (%) T/T, n (%) p M % T % p

Endurance 57 4 (7.0) 12 (21.1) 41 (71.9) .0961 17.5 82.5 .5179 Sprint 121 6 (5.0) 25 (20.6) 90 (74.4) .6796 15.3 84.7 .9528

Control 100 3 (3.0) 24 (24.0) 73 (73.0) - 15.0 85.0 -

表 4.5 受試者之 ACE、ACTN3 及 AGT 基因型勝算比1

Table 4.5 Odds ratio of ACE, ACTN3, and AGT genotypes for the participants.1

1Analyzed by χ2 test. CI: confidence interval.

Endurance/male (n = 57) Sprint/male (n = 89) Endurance/female (n = 57) Sprint/female (n = 121)

Odds ratio 95% CI Odds ratio 95% CI Odds ratio 95% CI Odds ratio 95% CI

ACE

II 0.25 0.06-0.97 4.08 1.04-16.05 3.44 1.20-9.85 0.29 0.10-0.83

DD 4.08 1.04-16.05 0.25 0.06-0.97 0.29 0.10-0.83 3.44 1.20-9.85

ACTN3

XX 2.10 0.94-4.68 0.48 0.21-1.07 5.52 2.41-12.63 0.18 0.08-0.42

RR 0.48 0.21-1.07 2.10 0.94-4.68 0.18 0.08-0.42 5.52 2.41-12.63

AGT

MM 1.16 0.32-4.20 0.86 0.24-3.10 1.44 0.44-4.74 0.69 0.21-2.30

TT 0.86 0.24-3.10 1.16 0.32-4.20 0.69 0.21-2.30 1.44 0.44-4.74

表 4.6 合併受試者之 ACE 與 ACTN3 genotypes.1

Table 4.6 Combination of ACE and ACTN3 genotypes of the participants.1

1p >.05, no significantly different. Comparison was made among the three groups of each gender, as analyzed by χ2 test.

ACTN3 ACE Endurance/male

n (%)

Sprint/male n (%)

Control/male n (%)

Endurance/female n (%)

Sprint/female n (%)

Control/female n (%)

RR II 7 (12.3) 22 (24.7) 14 (14.0) 4 (7.0) 13 (10.7) 10 (10.0)

RR ID 8 (14.0) 9 (9.7) 12 (12.0) 7 (12.3) 19 (15.7) 16 (16.0)

RR DD 2 (3.5) 1 (1.1) 4 (4.0) 2 (3.5) 8 (6.6) 0 (0)

RX II 9 (15.8) 22 (24.7) 26 (26.0) 11 (19.3) 24 (19.8) 20 (20.0)

RX ID 19 (33.3) 18 (20.2) 20 (20.0) 10 (17.5) 36 (29.8) 29 (29.0)

RX DD 1 (1.8) 2 (2.2) 10 (10.0) 5 (8.8) 6 (5.0) 7 (7.0)

XX II 4 (7.0) 3 (3.2) 8 (8.0) 6 (10.5) 4 (3.3) 8 (8.0)

XX ID 6 (10.5) 12 (13.5) 4 (4.0) 9 (15.8) 9 (7.4) 7 (7.0)

XX DD 1 (1.8) 0 (0) 2 (2.0) 3 (5.3) 2 (1.7) 3 (3.0)

表 4.7 合併受試者之 ACE 與 AGT genotypes.1

Table 4.7 Combination of ACE and AGT genotypes of the participants.1

1p >.05, no significantly different. Comparison was made among the three groups of each gender, as analyzed by χ2 test.

ACE AGT Endurance/male

n (%)

Sprint/male n (%)

Control/male n (%)

Endurance/female n (%)

Sprint/female n (%)

Control/female n (%)

II MM 3 (5.3) 3 (3.4) 4 (4.0) 5 (8.8) 5 (4.1) 2 (2.0)

II MT 5 (8.8) 10 (11.2) 6 (6.0) 5 (8.8) 10 (8.3) 13 (13.0)

II TT 11 (19.3) 34 (38.2) 38 (38.0) 18 (31.5) 26 (21.5) 26 (26.0)

ID MM 0 (0) 1 (1.1) 2 (2.0) 1 (1.8) 1 (0.8) 3 (3.0)

ID MT 13 (22.8) 5 (5.6) 6 (6.0) 3 (5.3) 13 (10.7) 21 (21.0)

ID TT 20 (35.0) 33 (37.2) 28 (28.0) 21 (36.8) 49 (40.5) 26 (26.0)

DD MM 0 (0) 0 (0) 2 (2.0) 0 (0) 0 (0) 0 (0)

DD MT 0 (0) 1 (1.1) 6 (6.0) 2 (3.5) 2 (1.7) 2 (2.0)

DD TT 5 (8.8) 2 (2.2) 8 (8.0) 2 (3.5) 15 (12.4) 7 (7.0)

表 4.8 男性受試者之食物攝取調查1

Table 4.8 Dietary survey of the male participants.1

1 p <.05, data (mean ± S.D.) with different letters were significantly different, as analyzed by one-way ANOVA. EX: exchange.

# P <.05, the comparison was made with the corresponding sprint group, as analyzed by t-test.

Male athletes (n = 146)

表 4.9 女性受試者之食物攝取調查1

Table 4.9 Dietary survey of the female participants.1

1 p <.05, data (mean ± S.D.) with different letters were significantly different, as analyzed by one-way ANOVA. EX: exchange.

# P <.05, the comparison was made with the corresponding sprint group, as analyzed by t-test.

Female athletes (n = 178)

表 4.10 男性受試者之熱量分配調查1

Table 4.10 Energy intake survey of the male participants.1

1 p <.05, data (mean ± S.D.) with different letters were significantly different, as analyzed by one-way ANOVA. Snack: consumed before supper, in addition to regular meals. Late snack:

consumed after supper and before sleep. Drinks: consumed all kinds of liquid, except pure water or dairy products.

# P <.05, the comparison was made with the corresponding sprint group, as analyzed by t-test.

Male athletes (n = 146)

Energy distribution (%)

Meal 70.3 ± 11.2 72.6 ± 12.3 73.0 ± 11.7 .5645

表 4.11 女性受試者之熱量分配調查1

Table 4.11 Energy intake survey of the female participants.1

1 p <.05, data (mean ± S.D.) with different letters were significantly different, as analyzed by one-way ANOVA. Snack: consumed before supper, in addition to regular meals. Late snack:

consumed after supper and before sleep. Drinks: consumed all kinds of liquid, except pure water or dairy products.

Energy distribution (%)

Meal 78.2 ± 7.8a 67.4 ± 12.9b 78.7 ± 11.2a <.0001

Snack 4.3 ± 3.4 6.5 ± 5.8 4.7 ± 4.5 .0753

Late

snack 4.0 ± 3.9 4.1 ± 3.7 2.8 ± 2.9 .4109

Drinks 10.1 ± 3.5ab 13.2 ± 9.3a 6.1 ± 5.8b .0013

表 4. 12 受試者之運動訓練時間1

Table 4.12 Exercise training time of the participants.1

1 p >.05, data (mean ± S.D.) were no significantly different, as analyzed by t-test.

Male (n = 146) Female (n = 178)

Endurance (n = 57)

Sprint (n = 89)

p Endurance (n = 57)

Sprint (n = 121)

p

Training hour

(hrs/day) 2.4 ± 0.9 2.5 ± 1.1 .6227 1.9 ± 0.5 2.1 ± 0.9 .5289

Training frequency (days/wk)

5.4 ± 0.9 5.3 ± 1.1 .4592 5.3 ± 1.0 5.0 ± 1.4 .2491 Training

duration (yrs) 8.7 ± 2.6 9.5 ± 2.9 .1416 7.9 ± 3.3 8.8 ± 3.3 .1947

表 4.13 男性受試者之身體組成分析1

Table 4.13 Body composition of the male participants.1

1 p <.05, data (mean ± S.D.) with different letters were significantly different, as analyzed by one-way ANOVA. TSF: triceps skinfold thickness; FFM: fat-free mass; TBW: total body water; BM: bone mass; DBUA: dominant calcaneus broadband ultrasound attenuation; NDBUA: non-dominant calcaneus broadband ultrasound attenuation; T-score: standard division from the mean of young’s bone mineral density. dB/MHz, decibels/megahertz.

Endurance

表 4.14 女性受試者之身體組成分析1

Table 4.14 Body composition of the female participants.1

1 p <.05, data (mean ± S.D.) with different letters were significantly different, as analyzed by one-way ANOVA. TSF: triceps skinfold thickness; FFM: fat-free mass; TBW: total body water; BM: bone mass; DBUA: dominant calcaneus broadband ultrasound attenuation; NDBUA: non-dominant calcaneus broadband ultrasound attenuation; T-score: standard division from the mean of young’s bone mineral density. dB/MHz, decibels/megahertz.

Endurance

表 4.15 不同 ACE 基因型受試者之除脂體重1

Table 4.15 Fat-free mass (%) among different ACE genotypes.1

1 p >.05, data (mean ± S.D.) were no significantly different, as analyzed by one-way ANOVA.

ACE genotypes

ACE II ACE ID ACE DD p

FFM (%)

Endurance/male 83.4 ± 4.1 (n = 14)

Endurance/female 78.1 ± 5.1 (n = 17)

Control/female 69.9 ± 6.2 (n = 40)

參考文獻 參考文獻 參考文獻 參考文獻

一、 中文部分

王順正 (1999a)。骨骼肌的類型骨骼肌的類型骨骼肌的類型骨骼肌的類型。運動生理週訊,30。

王順正 (1999b)。認認認認識無氧運動識無氧運動識無氧運動識無氧運動。運動生理週訊,34。

白禮源(譯) (1995)。甘龍醫用生理學上甘龍醫用生理學上甘龍醫用生理學上甘龍醫用生理學上、、、、下冊下冊下冊 (Review of medical physiology)。下冊 臺北市:藝軒。(原著出版年﹕1991 年)。

行政院衛生署 (1998)。台灣常見食品營養圖鑑台灣常見食品營養圖鑑台灣常見食品營養圖鑑台灣常見食品營養圖鑑((((編號編號編號編號::::016099860023))))。臺北市,

行政院衛生署。

行政院衛生署 (2003)。國人膳食營養素參考攝取量及其說明國人膳食營養素參考攝取量及其說明國人膳食營養素參考攝取量及其說明國人膳食營養素參考攝取量及其說明。臺北市:行政院 衛生署。

林正常 (2005)。運動生理學運動生理學運動生理學運動生理學。臺北市:師大書苑。

邱麗玲、謝玲玲、顏克典、謝伸裕 (2007)。ACTN3 與與 ACE 基因多形與 基因多形基因多形基因多形性與優秀性與優秀性與優秀性與優秀 爆發型運動員的相關性

爆發型運動員的相關性 爆發型運動員的相關性

爆發型運動員的相關性。體育學報,40,1-12 頁。

湯馥君、施嘉美、鄭景峰、賴淑萍、鄭小嵐、鄭榮生、張雅茹(譯)(2008) 。 Asker Jeukendrupand Michael Gleeson 著。運動營養學運動營養學運動營養學 (Sport nutrition: An 運動營養學 introduction to energy production and performance)。臺北市:禾楓。

賴淑萍 (2006)。大學生大學生大學生「大學生「「女運動員三症候群「女運動員三症候群女運動員三症候群」女運動員三症候群」」之相關探討」之相關探討之相關探討之相關探討。國立臺灣師範大學 人類發展與家庭學系,碩士論文,未出版,臺北市。

謝明家 (2000)。台灣第二型糖尿病人血管收縮素轉化酶之台灣第二型糖尿病人血管收縮素轉化酶之台灣第二型糖尿病人血管收縮素轉化酶之台灣第二型糖尿病人血管收縮素轉化酶之 DD 基因型的高出現基因型的高出現基因型的高出現 基因型的高出現 頻率頻率

頻率頻率。高雄醫學大學醫學研究所,碩士論文,未出版,高雄市。

二、 西文部分

Adhihetty, P. J., Irrcher, I., Joseph, A. M., Ljubicic, V., & Hood, D.A. (2003).

Plasticity of skeletal muscle mitochondria in response to contractile activity.

Experimental Physiology, 88(1): 99-107.

Alvarez, R., Terrados, N., Ortolano, R., Iglesias-Cubero, G., Reguero, J. R., Batalla, A., Cortina, A., Fernández-García, B., Rodríguez, C., Braga, S., Alvarez, V., & Coto, E.

(2000). Genetic variation in the renin-angiotensin system and athletic performance. European Journal of Applied Physiology, 82(1-2): 117-20.

American College of Sports Medicine. (2006). Guidelines for exercise testing and prescription. (7th Edition), Lippincott, Inc., PA, USA.

Amir, O., Amir, R., Yamin, C., Attias, E., Eynon, N., Sagiv, M., Sagiv, M., & Meckel, Y. (2007). The ACE deletion allele is associated with Israeli elite endurance athletes. Experimental Physiology, 92(5):881-886

Anastasiya, M. D., Ildus, I .A., Irina, V. A.,& Viktor, A. R. (2008). Association of the ACTN3 R577X polymorphism with power athlete status in Russians. European Journal of Applied Physiology, 103: 631-634

Andersen, P., & Henriksson, J. (1977). Training induced changes in the subgroups of human type II skeletal muscle fibres. Acta Physiologica Scandinavica, 99:

123-125.

Angyán, L., Téczely, T., Karsai, I., & Petofi, A. (2005). Comparative analysis of the effects of physical exercise. Acta Physiologica Hungarica, 92(1), 19-26.

Bailey, L.B. and Gregory, J.F. (1999). Polymorphism of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate

requirement. Journal of Nutrition, 129: 919-922.

Bale, P., Mayhew, J. L., Piper, F. C., Ball, T. E., & Willman, M. K. (1992). Biological and performance variables in relation to age in male and female adolescent athletes. The Journal of Sports Medicine and Physical Fitness, 32(2): 142-148.

Bassett, C. A. L. (1968). Biologic significance of piezoelectricity. Calcified Tissue International, 1: 252-272.

Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. The New England Journal of Medicine, 335:1-7.

Bennell, K. L., Malcolm, S. A., Khan, K. M., Thomas, S. A., Reid, S. J., Brukner, P. D., Ebeling, P. R., & Wark, J. D. (1997). Bone mass and bone turnover in power athletes, endurance athletes, and controls: a 12-month longitudinal study. Bone, 20(5): 477-84.

Berger, A., Mutch, D. M., German, J. B., & Roberts, M. A. (2002). Unraveling lipid metabolism with microarrays: Effects of arachidonate and docosahexaenoate acid on murine hepatic and hippocampal gene expression. GenomeBiology, 3:

0004.1-0004.53.

Brown, J. M., Boysen, M. S., Chung, S., Fabiyi, O., Morrison, R. F., Mandrup, S., &

McIntosh, M. K. (2004). Conjugated linoleic acid induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines. The Journal of Biological Chemistry, 279: 26735-26747.

Bruhat, A., Jousse, C., Wang, X. Z., Ron, D., Ferrara, M., & Fafournoux, P. (1997).

Amino acid limitation induces expression of CHOP, a CCAAT/ enhancer

binding protein-related gene, at both transcriptional and post-transcriptional levels. The Journal of Biological Chemistry, 272: 17588-17593.

Busjahn, A., Knoblauch, H., Knoblauch, M., Bohlender, J., Menz, M., Faulhaber, H.D., Becker, A., Schuster, H.,& Luft, F. C. (1997). Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions. A twin study. Hypertension, 29: 165-170.

Butterfield, G. E. & Calloway, D. H. (1984). Physical activity improves protein utilization in young men. British Journal of Nutrition, 51: 171-184.

Campbell, L. E., Wang, X., & Proud, C. G. (1999). Nutrients differentially regulate multiple translation factors and their control by insulin. Biochemical Journal, 344: 433-441.

Chavez, A., Munoz, & Chavez, M. (2003). Nutrigenomics in public health nutrition : short-term perspectives. European Journal of Clinical Nutrition, 57(1): S97-100.

Chen, J. J., Duan, T., Single, R., Mather, K., & Thomson, G. (2005). Hardy-Weinberg Testing of a Single Homozygous Genotype. Genetics, 170: 1439-1442.

Chiang, F. T., Chern, T. H., Lai, Z. P., Tseng, C. D., Hsu, K. L., Lo, H. M.,& Tseng, Y.

Z. (1996). Age- and gender-dependent association of the angiotensin- converting enzyme gene with essential hypertension in a Chinese population. Journal of Human Hypertension, 10: 823-826.

Chiang, F. T., Hsu, K. L., Tseng, C. D., Hsiao, W. H., Lo, H. M., Chern, T. H.,&

Tseng, Y. Z. (1997). Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. Journal of Hypertension, 15:

607-611.

Chuang, L. M., Chiu, K. C., Chiang, F. T., Lee, K. C., Wu, H. P., Lin, B. J., & Tai, T.

Y. (1997). Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism, 46: 1211-1214.

Chowanadisai, W., Kelleher, S.L., & Lonnderdal, B. (2004). Maternal zinc deficiency raises plasma prolactin levels in lactating rats. Journal of Nutrition, 134:

1314-1319.

Clarkson, P. M., Devaney, J. M., Gordish-Dressman, H., Thompson, P. D., Hubal, M.

J., Urso, M., Price, T. B., Angelopoulos, T. J., Gordon, P. M., Moyna, N. M., Pescatello L. S., Visich, P. S., Zoeller, R. F., Seip, R. L.,& Hoffman, E. P.

(2005). ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. Journal of Applied Physiology, 99(1):

154-163.

Collins, F. S., Lander, E. S., Rogers, J., & Waterston, R. H. (2004). Finishing the euchromatic sequence of the human genome. Nature, 431: 931-945.

Fafournoux, P., Bruhat, A., & Jousse, C. (2000). Amino acid regulation of gene expression. Biochemical Journal, 351: 1-12.

Farrell, P. A., & Barboriak, J. (1980). The time course of alterations in plasma lipid and lipoprotein concentrations during eight weeks of endurance training.

Atherosclerosis, 37: 231-238.

Fogg-Johnson, N. & Merolli, A. (2000). Nutrigenomics: The next wave in nutrition research. Nutrition, 3(3): 87-90.

Fox, E. L.& Bowers, R. (1988). Sprint and endurance training: methods and effects. In:

Sports physiology. (3rd Edition), pp 225-280. Dubuque, IA: Wm. C. Brown.

Freyssenet, D., Berthon, P., & Denis, C. (1996). Mitochondrial biogenesis in skeletal muscle in response to endurance exercises. Archives of Physiology and

Biochemistry, 104:129-41.

Gameau, L. J., Brown, L. D., Moore, M. A., Donnenhoffer, J. E., & Demyan, W. B.

(2005). Optimization of LightTyper genotyping assays. Biochemica, 3: 4-6.

Gayagay, G., Yu, B., Hambly, B., Boston, T., Hahn, A., Celermajer, D.S.,& Trent R.J.

(1998). Elite endurance athletes and the ACE I allele ---the role of genes in athletic performance. Human Genetics, 103: 48-50.

Gettman, L. R., Ward, P., & Hagan, R. D. (1981). Strength and endurance changes through circuit weight training. National Strength and Conditioning Association Journal, 3(4): 12-14.

Goel, H. & Mittal, B. (2007). ACTN3: Athlete gene prevalence in North India.

Current Science, 92(1): 84-86.

Goldspink, G. (1998). Selective gene expression during adaption of muscle in response to different physiological demands. Comparative Biochemistry and Physiology, 120: 5-15.

Gollnick, P.D., Armstrong, R.B., Saltin, B., Saubert, C. I., Sembrowich, W. L., &

Shepherd, R. E. (1973). Effect of training on enzyme activity and fiber composition of human skeletal muscle. Journal of Applied Physiology,, 34:

107–111.

Gollnick, P. D., Armstrong, R.B., Saubert, C. I., Piehl, K., & Saltin, B. (1972).

Enzyme activity and fiber composition in skeletal muscle of untrained and

trained men. European Journal of Applied Physiology, 33: 312–319.

Gordon, S., Davis, B. S., Carlson, C. J., & Booth, F. W. (2001). Ang II is required for optimal overload-induced skeletal muscle hypertrophy. American Journal of Physiology: Endocrinology and Metabolism, 280: E150–E159.

Guerrini, L., Gong, S. S., Mangasarian, K. & Basilico, C. (1993). Cis- and

trans-acting elements involved in amino acid regulation of asparagine synthetase gene expression. Molecular and Cellular Biology, 13: 3202-3212

Hammill, E., Wilson, R. S., & Johnston, I. A. (2004). Sustained swimming performance and muscle structure are altered by thermal acclimation in male mosquitofish. Journal of Thermal Biology, 29: 251–257.

Harrap, S. B., Tzourio, C., Cambien, F., Poirier, O., Raoux, S., Chalmers, J.,

Chapman, N., Colman, S., Leguennec, S., MacMahon, S., Neal, B., Ohkubo, T.,

& Woodward, M. (2003). The ACE gene ID polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.

Hypertention, 42: 297-303.

Harrigan, G. G., Brackett, D. J., & Boros, L. G. (2005). Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics. Mini Reviews in Medicinal Chemistry, 5:13-20.

Hasty, A. H., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Perrey, S., Yoshikawa, T., Osuga, J., Okazaki, H., Tamura, Y., Iizuka, Y., Shionoiri, F., Ohashi, K., Harada, K., Gotoda, T., Nagai, R., Ishibashi, S., & Yamada, N. (2000). Sterol regulatory element binding protein-1 is regulated by glucose at the

transcriptional level. The Journal of Biological Chemistry, 275: 31069-31077.

Heck, A. L., Barroso, C. S., Callie, M. E.,& Bray, M. S. (2004). Gene-nutrition interaction in human performance and exercise response. Nutrition, 20: 598-602.

Hillman, L. S. (1990). Nutritional factors affecting mineral homeostasis and

mineralization in the term and preterm ingant. In D. J. Simmons (Eds.), Nutrition and bone development (pp. 55-67). New York, NY: Oxford University.

Hoppeler, H. & Fluck, M. (2003). Plasticity of skeletal muscle mitochondria: structure and function. Medicine & Science in Sports & Exercise, 35(1): 95-104.

Hsieh, M. C., Lin, S. R., Hsieh, T. J., Hsu, C. H., Chen, H. C., Shin, S. J.,& Tsai, J. H.

Hsieh, M. C., Lin, S. R., Hsieh, T. J., Hsu, C. H., Chen, H. C., Shin, S. J.,& Tsai, J. H.

相關文件